READ

Why is this coronavirus such a threat?

Chances are you've had a coronavirus before. So why is this one so dangerous?
Thomas Crow
Thomas Crow
Freelance science writer
Why is this coronavirus such a threat?
Image credit: Getty Images

Every winter, there’s up to a 30% chance that the common cold you have is a coronavirus. So why is this new strain changing the world?

First, let’s get our terms down. A coronavirus is part of a group of viruses within the virus family Coronaviridae.

Coronaviruses include the strain responsible for the current global pandemic, the severe acute respiratory syndrome (SARS) virus of 2003, the Middle East respiratory syndrome (MERS, also known as camel flu) of 2012 and some of our seasonal colds.

The proper name for the virus we’re all dealing with right now is SARS-CoV-2. If this virus infects you, you may develop an illness called COVID-19, which is much more fatal than the seasonal flu.

A render of the SARS-CoV2 virus

Video credit: Brady Johnston
A render of the SARS-CoV2 virus

What we know

Researchers are still playing catch up to this deadly virus, but we do know some things.

Like others in its family, SARS-CoV-2 is a zoonotic virus – meaning it can spread from animals to humans.

By sequencing the virus’ genome and comparing it with its relatives, researchers found a similar coronavirus in bats.

But we still don’t know exactly how it was passed to humans.

What we do know is this new coronavirus is very good at what it does.

Viruses can’t reproduce on their own. Instead, they work their way into our cells and use them as factories to copy themselves.

View Larger

Turns out all those generic pictures of spiky balls…

Image credit: Getty images
A single SARS-CoV-2 coronavirus particle - round and orange with small red circular components around the edges
View Larger

…are actually more-or-less accurate.

Image credit: CSIRO

The SARS-CoV-2 virus is shaped like a spiked ball. The spikes are a protein that attaches itself to an enzyme on the outer surface of the cells in our lungs called ACE2.

These spikes have evolved to strongly attach to ACE2 enzyme. This strong attachment makes the virus more infectious.

The virus uses its spike proteins to puncture the cell wall and release a genetic code that reprograms a cell to make more copies of the virus.

But that spike protein can also be used to make a vaccine.

Get your clamp on

Dr Keith Chappell is part of a partnership, between the University of Queensland and the Australian Institute of Bioengineering and Nanotechnology, that is trying to develop a vaccine for COVID-19.

“Years of experience and automated experiments allowed us to find a clamp to hold viruses,” says Keith.

“We clone a molecular clamp with the DNA sequence encoding of the spike protein.”

The clamp holds just the spike, without a virus attached, so our immune system can learn about it. That gives our bodies the chance to recognise the spike when it is on a virus – and kill it before it can spread.

A molecular clamp wrapped around a viral spike.

Image credit: University of Queensland
A molecular clamp wrapped around a viral spike.

The Fast and the Furin-ous

Normally, once the spike has punctured the cell wall, an enzyme that naturally occurs in our cells called furin cuts the spike from the virus particle, letting it infect the cell.

But when the team tried to use furin to cut their molecular clamp, it didn’t work. Instead, they are testing other enzymes to release the spike proteins.

“We need to change the furin cutting site for our clamp, so we had to screen changes to find another site,” says Keith.

Keith’s team developed their work assuming the next pandemic would come from influenza. But applying their work to this different family of viruses means rebuilding their molecular clamp for a heavier load.

“The biggest challenge with coronavirus spike proteins is their size. They’re two-and-a-half times larger than the spike proteins found on influenza [making them difficult to hold].”

Don’t stop washing just yet

While we need vaccines to stop the virus’ spread, they are still some time away.

Currently, the best thing to slow COVID-19 is still social isolation, hand washing – and listening to health experts.

Thomas Crow
About the author
Thomas Crow
Thomas Crow is an Australian science writer. He has a background in professional writing, biochemistry and genetics. He writes for Australian and New Zealand research institutes and publications like Crikey. He's a horror and gothic fantasy fan. He thinks of himself as a gardener but scores of dead plants beg to differ.
View articles
Thomas Crow is an Australian science writer. He has a background in professional writing, biochemistry and genetics. He writes for Australian and New Zealand research institutes and publications like Crikey. He's a horror and gothic fantasy fan. He thinks of himself as a gardener but scores of dead plants beg to differ.
View articles

NEXT ARTICLE

We've got chemistry, let's take it to the next level!

Get the latest WA science news delivered to your inbox, every fortnight.

Republish

Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.

Guidelines

You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.

Images

Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.

Video

All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.

Contact

For more information about using our content, email us: particle@scitech.org.au

Copy this HTML into your CMS
Press Ctrl+C to copy